Alnylam Pharmaceuticals
ALNY
#541
Rank
NZ$74.71 B
Marketcap
NZ$565.57
Share price
0.31%
Change (1 day)
14.73%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company